"Designing Growth Strategies is in our DNA"

Central Lab Services Market Size, Share & Industry Analysis By Service Type (Safety Testing, Biomarker Testing, Genetic Testing, Immunology Testing, Anatomic Pathology & Histology, Microbiology & Infectious Disease Testing, Bioanalytical Testing, & Others), By Phase (Phase I, Phase II, Phase III, & Phase IV), By Modality (Small Molecules, Biologics, Medical Devices, & Others), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, Cardiology, & Others), By End User (Pharmaceutical & Biotechnological Companies, Medical Device Companies, CROs, & Others), and Regional Forecast, 2026-2034

Last Updated: June 24, 2026 | Format: PDF | Report ID: FBI107163

 

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Clinical Trials, Key Countries/Regions, 2025
    2. Overview of R&D Expenditures, Key Players
    3. Key Industry Developments - Mergers, Acquisitions & Partnerships
  5. Global Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Phase
      2. Canada
        1. By Phase
  7. Europe Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Phase
      2. Germany
        1. By Phase
      3. France
        1. By Phase
      4. Spain
        1. By Phase
      5. Italy
        1. By Phase
      6. Scandinavia
        1. By Phase
      7. Rest of Europe
        1. By Phase
  8. Asia Pacific Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Phase
      2. Australia
        1. By Phase
      3. China
        1. By Phase
      4. India
        1. By Phase
      5. Southeast Asia
        1. By Phase
      6. Rest of Asia Pacific
        1. By Phase
  9. Latin America Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
        1. By Phase
      2. Mexico
        1. By Phase
      3. Rest of Latin America
        1. By Phase
  10. Middle East & Africa Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
        1. By Phase
      2. South Africa
        1. By Phase
      3. Rest of Middle East & Africa
        1. By Phase
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Thermo Fisher Scientific Inc.
      2. ICON plc
      3. SGS Société Générale de Surveillance SA
      4. Labcorp
      5. IQVIA
      6. ACM Global Laboratories
      7. Nordic Bioscience
      8. Charles River Laboratories
      9. Eurofins Scientific
      10. Cerba Research
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Clinical Trials, Key Countries/Regions, 2025
    2. Overview of R&D Expenditures, Key Players
    3. Key Industry Developments - Mergers, Acquisitions & Partnerships
  5. Global Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Phase
      2. Canada
        1. By Phase
  7. Europe Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Phase
      2. Germany
        1. By Phase
      3. France
        1. By Phase
      4. Spain
        1. By Phase
      5. Italy
        1. By Phase
      6. Scandinavia
        1. By Phase
      7. Rest of Europe
        1. By Phase
  8. Asia Pacific Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Phase
      2. Australia
        1. By Phase
      3. China
        1. By Phase
      4. India
        1. By Phase
      5. Southeast Asia
        1. By Phase
      6. Rest of Asia Pacific
        1. By Phase
  9. Latin America Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
        1. By Phase
      2. Mexico
        1. By Phase
      3. Rest of Latin America
        1. By Phase
  10. Middle East & Africa Central Lab Services Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Service Type
      1. Safety Testing
      2. Biomarker Testing
      3. Genetic Testing
      4. Immunology Testing
      5. Anatomic Pathology & Histology
      6. Microbiology & Infectious Disease Testing
      7. Bioanalytical Testing
      8. Others
    2. Market Analysis, Insights and Forecast – By Phase
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Market Analysis, Insights and Forecast – By Modality
      1. Small Molecules
      2. Biologics
      3. Medical Devices
      4. Others
    4. Market Analysis, Insights and Forecast – By Therapeutic Area
      1. Oncology
      2. Infectious Diseases
      3. Neurology
      4. Cardiology
      5. Others
    5. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnological Companies
      2. Medical Device Companies
      3. CROs
      4. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
        1. By Phase
      2. South Africa
        1. By Phase
      3. Rest of Middle East & Africa
        1. By Phase
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Thermo Fisher Scientific Inc.
      2. ICON plc
      3. SGS Société Générale de Surveillance SA
      4. Labcorp
      5. IQVIA
      6. ACM Global Laboratories
      7. Nordic Bioscience
      8. Charles River Laboratories
      9. Eurofins Scientific
      10. Cerba Research
Read Less

Figure 1:  Global Central Lab Services Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2:  Global Central Lab Services Market Value Share (%), by Service Type, 2025 & 2034

Figure 3:  Global Central Lab Services Market Value Share (%), by Phase, 2025 & 2034

Figure 4:  Global Central Lab Services Market Value Share (%), by Modality, 2025 & 2034

Figure 5:  Global Central Lab Services Market Value Share (%), by Therapeutic Area, 2025 & 2034

Figure 6:  Global Central Lab Services Market Value Share (%), by End User, 2025 & 2034

Figure 7:  Global Central Lab Services Market Value Share (%), by Region, 2025 & 2034

Figure 8:  North America Central Lab Services Market Value (USD billion), by Service Type, 2025 & 2034

Figure 9:  North America Central Lab Services Market Value Share (%), by Service Type, 2025

Figure 10:  North America Central Lab Services Market Value (USD billion), by Phase, 2025 & 2034

Figure 11:  North America Central Lab Services Market Value Share (%), by Phase, 2025

Figure 12:  North America Central Lab Services Market Value (USD billion), by Modality, 2025 & 2034

Figure 13:  North America Central Lab Services Market Value Share (%), by Modality, 2025

Figure 14:  North America Central Lab Services Market Value (USD billion), by Therapeutic Area, 2025 & 2034

Figure 15:  North America Central Lab Services Market Value Share (%), by Therapeutic Area, 2025

Figure 16:  North America Central Lab Services Market Value (USD billion), by End User, 2025 & 2034

Figure 17:  North America Central Lab Services Market Value Share (%), by End User, 2025

Figure 18:  North America Central Lab Services Market Value (USD billion), By Country, 2025 & 2034

Figure 19:  North America Central Lab Services Market Value Share (%), By Country, 2025

Figure 20:  Europe Central Lab Services Market Value (USD billion), by Service Type, 2025 & 2034

Figure 21:  Europe Central Lab Services Market Value Share (%), by Service Type, 2025

Figure 22:  Europe Central Lab Services Market Value (USD billion), by Phase, 2025 & 2034

Figure 23:  Europe Central Lab Services Market Value Share (%), by Phase, 2025

Figure 24:  Europe Central Lab Services Market Value (USD billion), by Modality, 2025 & 2034

Figure 25:  Europe Central Lab Services Market Value Share (%), by Modality, 2025

Figure 26:  Europe Central Lab Services Market Value (USD billion), by Therapeutic Area, 2025 & 2034

Figure 27:  Europe Central Lab Services Market Value Share (%), by Therapeutic Area, 2025

Figure 28:  Europe Central Lab Services Market Value (USD billion), by End User, 2025 & 2034

Figure 29:  Europe Central Lab Services Market Value Share (%), by End User, 2025

Figure 30:  Europe Central Lab Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 31:  Europe Central Lab Services Market Value Share (%), By Country/ Sub-region, 2025

Figure 32:  Asia Pacific Central Lab Services Market Value (USD billion), by Service Type, 2025 & 2034

Figure 33:  Asia Pacific Central Lab Services Market Value Share (%), by Service Type, 2025

Figure 34:  Asia Pacific Central Lab Services Market Value (USD billion), by Phase, 2025 & 2034

Figure 35:  Asia Pacific Central Lab Services Market Value Share (%), by Phase, 2025

Figure 36:  Asia Pacific Central Lab Services Market Value (USD billion), by Modality, 2025 & 2034

Figure 37:  Asia Pacific Central Lab Services Market Value Share (%), by Modality, 2025

Figure 38:  Asia Pacific Central Lab Services Market Value (USD billion), by Therapeutic Area, 2025 & 2034

Figure 39:  Asia Pacific Central Lab Services Market Value Share (%), by Therapeutic Area, 2025

Figure 40:  Asia Pacific Central Lab Services Market Value (USD billion), by End User, 2025 & 2034

Figure 41:  Asia Pacific Central Lab Services Market Value Share (%), by End User, 2025

Figure 42:  Asia Pacific Central Lab Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 43:  Asia Pacific Central Lab Services Market Value Share (%), By Country/ Sub-region, 2025

Figure 44:  Latin America Central Lab Services Market Value (USD billion), by Service Type, 2025 & 2034

Figure 45:  Latin America Central Lab Services Market Value Share (%), by Service Type, 2025

Figure 46:  Latin America Central Lab Services Market Value (USD billion), by Phase, 2025 & 2034

Figure 47:  Latin America Central Lab Services Market Value Share (%), by Phase, 2025

Figure 48:  Latin America Central Lab Services Market Value (USD billion), by Modality, 2025 & 2034

Figure 49:  Latin America Central Lab Services Market Value Share (%), by Modality, 2025

Figure 50:  Latin America Central Lab Services Market Value (USD billion), by Therapeutic Area, 2025 & 2034

Figure 51:  Latin America Central Lab Services Market Value Share (%), by Therapeutic Area, 2025

Figure 52:  Latin America Central Lab Services Market Value (USD billion), by End User, 2025 & 2034

Figure 53:  Latin America Central Lab Services Market Value Share (%), by End User, 2025

Figure 54:  Latin America Central Lab Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 55:  Latin America Central Lab Services Market Value Share (%), By Country/ Sub-region, 2025

Figure 56:  Middle East & Africa Central Lab Services Market Value (USD billion), by Service Type, 2025 & 2034

Figure 57:  Middle East & Africa Central Lab Services Market Value Share (%), by Service Type, 2025

Figure 58:  Middle East & Africa Central Lab Services Market Value (USD billion), by Phase, 2025 & 2034

Figure 59:  Middle East & Africa Central Lab Services Market Value Share (%), by Phase, 2025

Figure 60:  Middle East & Africa Central Lab Services Market Value (USD billion), by Modality, 2025 & 2034

Figure 61:  Middle East & Africa Central Lab Services Market Value Share (%), by Modality, 2025

Figure 62:  Middle East & Africa Central Lab Services Market Value (USD billion), by Therapeutic Area, 2025 & 2034

Figure 63:  Middle East & Africa Central Lab Services Market Value Share (%), by Therapeutic Area, 2025

Figure 64:  Middle East & Africa Central Lab Services Market Value (USD billion), by End User, 2025 & 2034

Figure 65:  Middle East & Africa Central Lab Services Market Value Share (%), by End User, 2025

Figure 66:  Middle East & Africa Central Lab Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 67:  Middle East & Africa Central Lab Services Market Value Share (%), By Country/ Sub-region, 2025

Figure 68:  Global Central Lab Services Market Share (%), By Company, 2025

Table 1:  Global Central Lab Services Market Revenue (USD billion) Forecast, by Service Type, 2021–2034

Table 2:  Global Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 3:  Global Central Lab Services Market Revenue (USD billion) Forecast, by Modality, 2021–2034

Table 4:  Global Central Lab Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034

Table 5:  Global Central Lab Services Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 6:  Global Central Lab Services Market Revenue (USD billion) Forecast, by Region, 2021–2034

Table 7:  North America Central Lab Services Market Revenue (USD billion) Forecast, by Service Type, 2021–2034

Table 8:  North America Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 9:  North America Central Lab Services Market Revenue (USD billion) Forecast, by Modality, 2021–2034

Table 10:  North America Central Lab Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034

Table 11:  North America Central Lab Services Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 12:  North America Central Lab Services Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 13:  U.S. Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 14:  Canada Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 15:  Europe Central Lab Services Market Revenue (USD billion) Forecast, by Service Type, 2021–2034

Table 16:  Europe Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 17:  Europe Central Lab Services Market Revenue (USD billion) Forecast, by Modality, 2021–2034

Table 18:  Europe Central Lab Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034

Table 19:  Europe Central Lab Services Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 20:  Europe Central Lab Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 21:  Germany Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 22:  U.K. Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 23:  France Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 24:  Italy Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 25:  Spain Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 26:  Scandinavia Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 27:  Rest of Europe Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 28:  Asia Pacific Central Lab Services Market Revenue (USD billion) Forecast, by Service Type, 2021–2034

Table 29:  Asia Pacific Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 30:  Asia Pacific Central Lab Services Market Revenue (USD billion) Forecast, by Modality, 2021–2034

Table 31:  Asia Pacific Central Lab Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034

Table 32:  Asia Pacific Central Lab Services Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 33:  Asia Pacific Central Lab Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 34:  China Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 35:  Japan Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 36:  India Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 37:  Australia Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 38:  Southeast Asia Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 39:  Rest of Asia Pacific Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 40:  Latin America Central Lab Services Market Revenue (USD billion) Forecast, by Service Type, 2021–2034

Table 41:  Latin America Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 42:  Latin America Central Lab Services Market Revenue (USD billion) Forecast, by Modality, 2021–2034

Table 43:  Latin America Central Lab Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034

Table 44:  Latin America Central Lab Services Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 45:  Latin America Central Lab Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 46:  Brazil Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 47:  Mexico Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 48:  Rest of Latin America Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 49:  Middle East & Africa Central Lab Services Market Revenue (USD billion) Forecast, by Service Type, 2021–2034

Table 50:  Middle East & Africa Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 51:  Middle East & Africa Central Lab Services Market Revenue (USD billion) Forecast, by Modality, 2021–2034

Table 52:  Middle East & Africa Central Lab Services Market Revenue (USD billion) Forecast, by Therapeutic Area, 2021–2034

Table 53:  Middle East & Africa Central Lab Services Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 54:  Middle East & Africa Central Lab Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 55:  GCC Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 56:  South Africa Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Table 57:  Rest of Middle East & Africa Central Lab Services Market Revenue (USD billion) Forecast, by Phase, 2021–2034

Central Lab Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 261
Download Free Sample

    man icon
    Mail icon
    Captcha refresh

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Customize Now
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports